NO20054417L - Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter - Google Patents

Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter

Info

Publication number
NO20054417L
NO20054417L NO20054417A NO20054417A NO20054417L NO 20054417 L NO20054417 L NO 20054417L NO 20054417 A NO20054417 A NO 20054417A NO 20054417 A NO20054417 A NO 20054417A NO 20054417 L NO20054417 L NO 20054417L
Authority
NO
Norway
Prior art keywords
tablets
fibrate
prepared
preparation
pharmaceutical preparations
Prior art date
Application number
NO20054417A
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Sarl Galenix Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarl Galenix Innovations filed Critical Sarl Galenix Innovations
Publication of NO20054417L publication Critical patent/NO20054417L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Det beskrives en fremgangsmåte for fremstilling av et farmasøytisk preparat hvori aktiv bestanddel inneholder fenofibrat eller et derivat derav, eventuelt i kombinasjon med en andre, aktiv bestanddel, i form av tabletter, der fremgangsmåten omfatter komprimering av den aktive bestanddel og eksipienter ved hjelp av en tørrgranuleringsmetode.
NO20054417A 2003-02-28 2005-09-23 Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter NO20054417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302520A FR2851734B1 (fr) 2003-02-28 2003-02-28 Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
PCT/FR2004/050090 WO2004078108A2 (fr) 2003-02-28 2004-02-27 Comprime de fenofibrate et procede de fabrication

Publications (1)

Publication Number Publication Date
NO20054417L true NO20054417L (no) 2005-09-23

Family

ID=32843093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054417A NO20054417L (no) 2003-02-28 2005-09-23 Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter

Country Status (20)

Country Link
US (1) US20060177499A1 (no)
EP (1) EP1601346B1 (no)
JP (1) JP2006520770A (no)
CN (1) CN100479808C (no)
AT (1) ATE439125T1 (no)
AU (1) AU2004216869B2 (no)
BR (1) BRPI0407850A (no)
CA (1) CA2517429C (no)
DE (1) DE602004022515D1 (no)
FR (1) FR2851734B1 (no)
IL (1) IL170507A (no)
MA (1) MA27662A1 (no)
MX (1) MXPA05009113A (no)
NO (1) NO20054417L (no)
NZ (1) NZ542039A (no)
PL (1) PL378106A1 (no)
RU (1) RU2362547C2 (no)
TN (1) TNSN05203A1 (no)
WO (1) WO2004078108A2 (no)
ZA (1) ZA200506992B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006273849A (ja) * 2005-03-02 2006-10-12 Aska Pharmaceutical Co Ltd フェノフィブラート含有組成物
NZ572106A (en) * 2006-03-31 2010-12-24 Rubicon Res Private Ltd Directly compressible composite for orally disintegrating tablets
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
JP5452051B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシン含有口腔内崩壊錠
CN102675748A (zh) * 2012-05-22 2012-09-19 苏州新区华士达工程塑胶有限公司 一种耐候聚丙烯的配方
WO2018149952A1 (en) * 2017-02-20 2018-08-23 Dsm Ip Assets B.V. Process for producing coated particles
KR102271734B1 (ko) * 2020-10-21 2021-07-01 한국프라임제약주식회사 건식과립공정용 멀티비타민 약제학적 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6180138B1 (en) * 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
JP5102423B2 (ja) * 2000-04-20 2012-12-19 オバン・エナジー・リミテッド 改善された水不溶性薬剤粒子の処理
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
EP1364646A4 (en) * 2001-03-01 2005-08-03 Grelan Pharmaceutical Co FENOFIBRATE CONTAINING COMPOSITION

Also Published As

Publication number Publication date
AU2004216869B2 (en) 2009-05-14
CA2517429C (fr) 2012-04-17
AU2004216869A1 (en) 2004-09-16
RU2362547C2 (ru) 2009-07-27
ZA200506992B (en) 2007-04-25
PL378106A1 (pl) 2006-03-06
FR2851734B1 (fr) 2006-06-09
TNSN05203A1 (fr) 2007-06-11
MXPA05009113A (es) 2006-05-31
WO2004078108A3 (fr) 2004-12-09
US20060177499A1 (en) 2006-08-10
ATE439125T1 (de) 2009-08-15
CN1780606A (zh) 2006-05-31
WO2004078108A2 (fr) 2004-09-16
MA27662A1 (fr) 2005-12-01
CA2517429A1 (fr) 2004-09-16
DE602004022515D1 (de) 2009-09-24
BRPI0407850A (pt) 2006-03-14
FR2851734A1 (fr) 2004-09-03
RU2005130155A (ru) 2006-06-10
EP1601346A2 (fr) 2005-12-07
NZ542039A (en) 2008-08-29
JP2006520770A (ja) 2006-09-14
CN100479808C (zh) 2009-04-22
IL170507A (en) 2011-11-30
EP1601346B1 (fr) 2009-08-12

Similar Documents

Publication Publication Date Title
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
NO340679B1 (no) Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
NO20062619L (no) Doseringssystem med kontrollert frigivning for nasale anvendelser
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
EA200401583A1 (ru) Таблетка лазофоксифена и ее покрытие
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
NO20051261L (no) Morfin-6-glukuronidsalt
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
NO20075508L (no) Stannsoporfinpreparater og administrering
NO20042022L (no) Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen
CA2532714A1 (en) Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
DK1499278T3 (da) Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
NO20013901L (no) Umettede kolestanderivater og deres anvendelse for fremstilling av meioseregulerende medikamenter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application